文献速递类风湿关节炎

类风湿关节炎中肿瘤坏死因子α诱导B10与B10pro细胞呈现促炎表型

Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2024-04-11

该研究分析健康人与类风湿关节炎(RA)患者B10及B10pro细胞的数量与功能,发现TNF-α下调IL-10并上调干扰素-γ和IL-17A,使B10与B10pro细胞呈现促炎表型;RA患者中B10与B10pro细胞受损且促炎表型加重,抗TNF治疗可恢复其数量与免疫抑制功能。

要点

  • TNF-α是B10细胞的关键决定因素,可下调IL-10并上调干扰素-γ和IL-17A。
  • RA患者B10与B10pro细胞数量减少且促炎表型加重。
  • 抗TNF治疗可恢复RA患者B10与B10pro细胞数量及免疫抑制功能。

核心结论

  • TNF-α通过干扰SHIP-1促使RA中B10与B10pro细胞呈现促炎表型,参与疾病发生。
  • 恢复B10与B10pro细胞的免疫抑制特性可能成为RA的新治疗途径(作者认为)。

研究设计与样本

  • 研究分析健康个体与RA患者B10和B10pro细胞的频率与功能。
  • 评估促炎细胞因子(尤其TNF-α)对RA患者这些细胞数量、稳定性与致病表型的影响,并在抗TNF治疗前后比较。
  • 通过单细胞RNA测序数据库再分析、转录组测序及TNF-α-/-与B细胞特异性SHIP-1-/-小鼠疾病模型研究机制。

主要发现

  • TNF-α下调IL-10并上调干扰素-γ和IL-17A,使B10与B10pro细胞呈现促炎特征。
  • RA患者B10与B10pro细胞受损且促炎表型加重。
  • 抗TNF治疗有效恢复RA患者B10与B10pro细胞的频率与免疫抑制功能,与TNF-α-/-小鼠中B10细胞增加一致。
  • TNF-α通过抑制糖酵解与增殖减少B10与B10pro细胞。
  • TNF-α调控B10与B10pro细胞的磷脂酰肌醇磷酸信号并降低SHIP-1表达。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: B10 and B10pro cells suppress immune responses via secreting interleukin (IL)-10. However, their regulators and underlying mechanisms, especially in human autoimmune diseases, are elusive. This study aimed to address these questions in rheumatoid arthritis (RA), one of the most common highly disabling autoimmune diseases. METHODS: The frequencies and functions of B10 and B10pro cells in healthy individuals and patients with RA were first analysed. The effects of proinflammatory cytokines, particularly tumour necrosis factor (TNF)-α on the quantity, stability and pathogenic phenotype of these cells, were then assessed in patients with RA before and after anti-TNF therapy. The underlying mechanisms were further investigated by scRNA-seq database reanalysis, transcriptome sequencing, TNF-α-/- and B cell-specific SHIP-1-/- mouse disease model studies. RESULTS: TNF-α was a key determinant for B10 cells. TNF-α elicited the proinflammatory feature of B10 and B10pro cells by downregulating IL-10, and upregulating interferon-γ and IL-17A. In patients with RA, B10 and B10pro cells were impaired with exacerbated proinflammatory phenotype, while anti-TNF therapy potently restored their frequencies and immunosuppressive functions, consistent with the increased B10 cells in TNF-α-/- mice. Mechanistically, TNF-α diminished B10 and B10pro cells by inhibiting their glycolysis and proliferation. TNF-α also regulated the phosphatidylinositol phosphate signalling of B10 and B10pro cells and dampened the expression of SHIP-1, a dominant phosphatidylinositol phosphatase regulator of these cells. CONCLUSIONS: TNF-α provoked the proinflammatory phenotype of B10 and B10pro cells by disturbing SHIP-1 in RA, contributing to the disease development. Reinstating the immunosuppressive property of B10 and B10pro cells might represent novel therapeutic approaches for RA.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Hu F, Shi L, Liu X, et al. Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-α in rheumatoid arthritis. Ann Rheum Dis. 2024. PMID: 38302261. doi:10.1136/ard-2023-224878

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。